CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo could turn inoperable lung cancer into operable disease
Disease control Recruiting nowThis study tests whether a new drug called IBI363, combined with chemotherapy, can shrink stage III lung cancer that cannot be surgically removed. The goal is to make the cancer small enough for surgery. About 43 adults with this type of lung cancer will take part. The main focus…
Matched conditions: CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New chemo drug aims to keep lung cancer away after surgery
Disease control Recruiting nowThis study tests a new chemotherapy drug called SMS001 in 42 people with non-small cell lung cancer (stages Ib to IIIa). The goal is to find a safe dose and see if it can prevent the cancer from returning after surgery. Participants will receive SMS001 as an extra treatment after…
Matched conditions: CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC